Becton Dickinson stock heads into the open after a 0.2% dip
Published on 09/21/2026 at 05:28 | Editorial responsibility: Rafael MĂĽller, Editor-in-Chief AD HOC NEWS
Becton Dickinson stock closed at USD 180.94 on the New York Stock Exchange on September 18, 2026, reflecting a 0.24% decline from the prior session in a move that stayed within the day’s quoted trading range per NYSE data reported by market overviews. The stock’s modest loss contrasted with a mixed broader market performance, underscoring stock-specific factors highlighted in recent coverage. Today, the shares head into the open with investors still digesting fresh regulatory developments that emerged over the weekend.
September 18, 2026 in numbers
Becton Dickinson and Company (ISIN US0718131099, NYSE: BDX) ended trading on September 18, 2026 at a closing price of USD 180.94 on the New York Stock Exchange, down 0.44 dollars or 0.24% from the previous close of USD 181.38 according to data cited in an NYSE-based overview published by ad-hoc-news.de. Intraday on September 18, 2026, the shares were quoted around USD 180.60 late in the morning Eastern Time, keeping the close within the reported session range and confirming that the stock stayed between the day’s high and low per the same overview from ad-hoc-news.de. With a market capitalization around USD 52,000,000,000 as of September 18, 2026 per that session snapshot, the move marked a contained adjustment rather than a break from the stock’s established capitalization range.
Over the same session, major United States equity benchmarks showed a mixed pattern, with the Dow Jones Industrial Average slipping modestly and the Nasdaq Composite posting a gain, as reported in a United States market wrap by Taiwan Television. That backdrop meant Becton Dickinson’s 0.24% decline on September 18, 2026 slightly lagged the technology-heavy Nasdaq but was broadly in line with the softer Dow performance, suggesting that company-specific news rather than index direction played a larger role in shaping the stock’s modest downside.
Regulatory focus today
Heading into today’s session on September 21, 2026, attention around Becton Dickinson centers on regulatory developments disclosed in a report that detailed an SEC cease and desist settlement addressing past Alaris infusion pump risk disclosures, including a civil penalty and the creation of a Fair Fund for investors, as highlighted by Yahoo Finance on September 20, 2026. The settlement terms and investor remediation framework described in that coverage remain a key narrative for the stock today, as market participants assess potential implications for reputation, compliance costs and any follow-on actions in the healthcare regulatory space. In addition, the company has a previously announced quarterly dividend scheduled to be paid on September 30, 2026, a cash return highlighted in an institutional holding update from MarketBeat, which may further shape income-focused investor sentiment as the ex-dividend and payment dates approach.
